V Square Quantitative Management LLC Sells 3,531 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• V Square Quantitative Management LLC sold 3,531 shares of GE HealthCare Technologies, reducing its stake by 37.5%, leaving it with a total of 5,897 shares valued at approximately $437,000.
• Institutional investors own 82.06% of GE HealthCare Technologies, indicating strong endorsement from major financial institutions.
• GE HealthCare Technologies announced a quarterly dividend of $0.035 per share, with the record date set for October 24th, translating to an annualized yield of 0.2%.

V Square Quantitative Management LLC decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 37.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,897 shares of the company's stock after selling 3,531 shares during the period. V Square Quantitative Management LLC's holdings in GE HealthCare Technologies were worth $437,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Fort Washington Investment Advisors Inc. OH boosted its holdings in GE HealthCare Technologies by 4.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company's stock valued at $263,000 after acquiring an additional 143 shares during the last quarter. WD Rutherford LLC boosted its holdings in GE HealthCare Technologies by 1.8% in the second quarter. WD Rutherford LLC now owns 22,647 shares of the company's stock valued at $1,677,000 after acquiring an additional 390 shares during the last quarter. Valicenti Advisory Services Inc. bought a new position in GE HealthCare Technologies in the second quarter valued at about $4,115,000. Meridian Investment Counsel Inc. boosted its holdings in GE HealthCare Technologies by 14.6% in the second quarter. Meridian Investment Counsel Inc. now owns 6,367 shares of the company's stock valued at $472,000 after acquiring an additional 812 shares during the last quarter. Finally, Old Port Advisors boosted its holdings in GE HealthCare Technologies by 13.3% in the second quarter. Old Port Advisors now owns 4,641 shares of the company's stock valued at $344,000 after acquiring an additional 543 shares during the last quarter. Institutional investors own 82.06% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on GEHC shares. Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a report on Thursday, September 18th. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Wall Street Zen cut GE HealthCare Technologies from a "buy" rating to a "hold" rating in a report on Saturday, September 20th. Citigroup raised their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. Finally, Zacks Research upgraded GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $86.89.

GE HealthCare Technologies Trading Up 2.8%

NASDAQ:GEHC opened at $75.10 on Wednesday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The stock has a market capitalization of $34.29 billion, a PE ratio of 15.39, a price-to-earnings-growth ratio of 2.79 and a beta of 1.13. The business's 50-day simple moving average is $74.30 and its 200-day simple moving average is $72.67.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. During the same quarter in the previous year, the business posted $1.00 EPS. GE HealthCare Technologies's revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies's payout ratio is 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.